Oxford’s COVID-19 vaccine is starting to look like a winner

Oxford researchers have developed a potential vaccine for COVID-19. Early testing in more than 1,000 clinical trial participants indicates the treatment is both safe and effective. Epidemiology breakthroughs aren’t our usual subject matter here at TNW, but the opportunity to finally publish some actual good news about the COVID-19 pandemic was just too much for us to pass up. The team, which included researchers from Oxford, and the Philipps University of  Marburg, Germany, developed the vaccine, called chimpanzee adenovirus-vectored vaccine (ChAdOx1 nCoV-19), by genetically-engineering a different virus known to cause the common cold in chimpanzees. While ChAdOx1nCoV-19 isn’t the first or…

This story continues at The Next Web